Jale Özyurt1, Christiane M Thiel2, Anna Lorenzen3, Ursel Gebhardt4, Gabriele Calaminus5, Monika Warmuth-Metz6, Hermann L Müller4. 1. Biological Psychology Laboratory, Department of Psychology, Carl von Ossietzky University, Oldenburg, Germany. 2. Biological Psychology Laboratory, Department of Psychology, Carl von Ossietzky University, Oldenburg, Germany; Research Center for Neurosensory Science, Carl von Ossietzky University, Oldenburg, Germany. 3. Biological Psychology Laboratory, Department of Psychology, Carl von Ossietzky University, Oldenburg, Germany; Center for Integrative Psychiatry, Department of Child and Adolescent Psychiatry and Psychotherapy, Christian Albrechts University School of Medicine, Kiel, Germany. 4. Department of Pediatrics and Pediatric Hematology and Oncology, Center for Child and Adolescent Medicine, Klinikum Oldenburg, Oldenburg, Germany. 5. Department of Pediatric Hematology and Oncology, Münster University Hospital, Münster, Germany. 6. Department of Neuroradiology, Würzburg University Hospital, Würzburg, Germany.
Abstract
OBJECTIVE: To test memory performance and executive functions in patients with childhood craniopharyngioma and hypothalamic involvement. STUDY DESIGN: Using standardized neuropsychological tests, we compared cognitive performance in a group of 15 patients with childhood craniopharyngioma and known hypothalamic involvement and a group of 24 age- and intelligence-matched control subjects. In addition, we compared individual patients' results with normative data to detect abnormal performance in the clinically relevant range. Within the patient group, we further tested whether the grade of hypothalamic involvement had an impact on cognitive performance and quality of life. RESULTS: Relative to healthy controls, the patients demonstrated significantly lower performance scores in tests of memory and executive functioning. On the individual performance level, delayed recall performance was severely impaired in one-third of the patients. Compared with patients with low-grade hypothalamic involvement, those with high-grade hypothalamic involvement showed worse performance in executive functions and reduced functional capabilities for daily life actions, indicating lower quality of life. CONCLUSION: Our findings demonstrate that hypothalamic involvement is related to impairments in memory and executive functioning in patients with childhood craniopharyngioma and indicate that a high grade of hypothalamic involvement is related to worse outcomes.
OBJECTIVE: To test memory performance and executive functions in patients with childhood craniopharyngioma and hypothalamic involvement. STUDY DESIGN: Using standardized neuropsychological tests, we compared cognitive performance in a group of 15 patients with childhood craniopharyngioma and known hypothalamic involvement and a group of 24 age- and intelligence-matched control subjects. In addition, we compared individual patients' results with normative data to detect abnormal performance in the clinically relevant range. Within the patient group, we further tested whether the grade of hypothalamic involvement had an impact on cognitive performance and quality of life. RESULTS: Relative to healthy controls, the patients demonstrated significantly lower performance scores in tests of memory and executive functioning. On the individual performance level, delayed recall performance was severely impaired in one-third of the patients. Compared with patients with low-grade hypothalamic involvement, those with high-grade hypothalamic involvement showed worse performance in executive functions and reduced functional capabilities for daily life actions, indicating lower quality of life. CONCLUSION: Our findings demonstrate that hypothalamic involvement is related to impairments in memory and executive functioning in patients with childhood craniopharyngioma and indicate that a high grade of hypothalamic involvement is related to worse outcomes.
Authors: Ashley S Fournier-Goodnight; Jason M Ashford; Thomas E Merchant; Frederick A Boop; Daniel J Indelicato; Lei Wang; Hui Zhang; Heather M Conklin Journal: J Neurooncol Date: 2017-05-24 Impact factor: 4.130
Authors: Heather M Conklin; Kirsten K Ness; Jason M Ashford; Matthew A Scoggins; Robert J Ogg; Yuanyuan Han; Yimei Li; Julie A Bradley; Frederick A Boop; Thomas E Merchant Journal: J Int Neuropsychol Soc Date: 2019-04 Impact factor: 2.892
Authors: Lisa M Jacola; Heather M Conklin; Matthew A Scoggins; Jason M Ashford; Thomas E Merchant; Belinda N Mandrell; Robert J Ogg; Elizabeth Curtis; Merrill S Wise; Daniel J Indelicato; Valerie M Crabtree Journal: J Pediatr Psychol Date: 2016-05-16
Authors: Rachel K Peterson; Jason M Ashford; Sarah M Scott; Fang Wang; Hui Zhang; Julie A Bradley; Thomas E Merchant; Heather M Conklin Journal: Pediatr Blood Cancer Date: 2018-06-22 Impact factor: 3.167
Authors: Jacob M Gump; Andrew M Donson; Diane K Birks; Vladimir M Amani; Karun K Rao; Andrea M Griesinger; B K Kleinschmidt-DeMasters; James M Johnston; Richard C E Anderson; Amy Rosenfeld; Michael Handler; Lia Gore; Nicholas Foreman; Todd C Hankinson Journal: Acta Neuropathol Commun Date: 2015-05-21 Impact factor: 7.801